Croda posts transcript of 2026 half-year results call

• Croda discussed H1 2026 results on a 28 July call attended by CEO Steve Foots, CFO Stephen Oxley, IR director David Bishop.
• H1 constant-currency sales rose 5% to GBP 881 million; adjusted operating profit increased 7% to GBP 156 million; EPS grew 9% to 78p.
• Interim dividend set at 48p; free cash flow improved to GBP 38 million; net debt GBP 578 million; leverage 1.4x EBITDA.
• Outlook maintained: organic sales growth of 3%-6% in 2026 with further adjusted operating margin expansion; adjusted operating profit expectations unchanged.
• Beauty Actives sales jumped 27%; management expects continued Consumer Care strength, with H2 lift from Pharma Solutions phasing and modest Crop improvement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Croda International plc published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.